Literature DB >> 30381007

Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.

Ana Canadas1, Miguel França2, Cristina Pereira3, Raquel Vilaça4, Hugo Vilhena5,6,7, Flora Tinoco8, Maria João Silva9, Jorge Ribeiro2, Rui Medeiros10, Pedro Oliveira11, Patrícia Dias-Pereira1, Marta Santos12.   

Abstract

Histopathology remains the cornerstone for diagnosing canine mammary tumors (CMTs). Recently, 2 classification systems (the World Health Organization [WHO] classification of 1999 and the proposal of 2011) and 2 grading methods based on the human Nottingham grade have been used by pathologists. Despite some evidence that the histological subtype and grade are prognostic factors, there is no comprehensive comparative study of these classification and grading systems in the same series of CMTs. In this study, the 2 classifications and the 2 grading methods were simultaneously applied to a cohort of 134 female dogs with CMTs. In 85 animals with malignant tumors, univariable and multivariable survival analyses were performed. Using the 2 systems, the proportion of benign (161/305, 53%) and malignant (144/305, 47%) tumors was similar and no significant differences existed in categorization of benign tumors. However, the 2011 classification subdivided malignant tumors in more categories-namely, those classified as complex, solid, and tubulopapillary carcinomas by the WHO system. Histological subtype according to both systems was significantly associated with survival. Carcinomas arising in benign tumors, complex carcinomas, and mixed carcinomas were associated with a better prognosis. In contrast, carcinosarcomas and comedocarcinomas had a high risk of tumor-related death. Slight differences existed between the 2 grading methods, and grade was related to survival only in univariable analysis. In this cohort, age, completeness of surgical margins, and 2 index formulas adapted from human breast cancer studies (including tumor size, grade, and vascular/lymph node invasion) were independent prognostic factors.

Entities:  

Keywords:  canine mammary tumors; classification; grade; prognosis; survival

Mesh:

Year:  2018        PMID: 30381007     DOI: 10.1177/0300985818806968

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  16 in total

1.  MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.

Authors:  Eman S Ramadan; Noha Y Salem; Ibrahim A Emam; Naglaa A AbdElKader; Haithem A Farghali; Marwa S Khattab
Journal:  Vet Res Commun       Date:  2021-11-17       Impact factor: 2.459

2.  Clinicopathological Analysis of Expression of Enhancer of Zeste Homologue 2 in Canine Mammary Carcinoma.

Authors:  Xiaoli Ren; Yuying Fan; Yongqi Li; Dongmei Shi; Yun Liu
Journal:  J Vet Res       Date:  2022-07-05       Impact factor: 2.058

3.  Expression of tumour transcription factor GLI1 in canine mammary tumours tissue.

Authors:  Penggang Liu; Yurong Lu; Yang Yang; Xueli Chen; Wenbing Xiong; Jing Sun
Journal:  Vet Med Sci       Date:  2022-06-06

Review 4.  Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.

Authors:  Haodi Dong; Hongxiu Diao; Ying Zhao; Huihao Xu; Shimin Pei; Jiafeng Gao; Jie Wang; Tariq Hussain; Deming Zhao; Xiangmei Zhou; Degui Lin
Journal:  Cell Prolif       Date:  2019-07-02       Impact factor: 6.831

5.  Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer.

Authors:  Su-Jin Jeong; Kang-Hoon Lee; A-Reum Nam; Je-Yoel Cho
Journal:  Cancers (Basel)       Date:  2019-09-29       Impact factor: 6.639

Review 6.  Hormonal Carcinogenesis in Canine Mammary Cancer: Molecular Mechanisms of Estradiol Involved in Malignant Progression.

Authors:  Cristian G Torres; María P Iturriaga; Pamela Cruz
Journal:  Animals (Basel)       Date:  2021-02-26       Impact factor: 2.752

7.  Proteomic Analysis Identifies FNDC1, A1BG, and Antigen Processing Proteins Associated with Tumor Heterogeneity and Malignancy in a Canine Model of Breast Cancer.

Authors:  Yonara G Cordeiro; Leandra M Mulder; René J M van Zeijl; Lindsay B Paskoski; Peter van Veelen; Arnoud de Ru; Ricardo F Strefezzi; Bram Heijs; Heidge Fukumasu
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

8.  Evaluating optical coherence tomography for surgical margin assessment of canine mammary tumours.

Authors:  Carolina Fabelo; Laura E Selmic; Pin-Cheh Huang; Jonathan P Samuelson; Jennifer K Reagan; Alexandra Kalamaras; Vincent Wavreille; Guillermo L Monroy; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2020-07-26       Impact factor: 2.613

9.  Estrogen receptors genotypes and canine mammary neoplasia.

Authors:  Ana Canadas-Sousa; Marta Santos; Bárbara Leal; Rui Medeiros; Patrícia Dias-Pereira
Journal:  BMC Vet Res       Date:  2019-09-10       Impact factor: 2.741

10.  Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas.

Authors:  Florian Chocteau; Jérôme Abadie; Delphine Loussouarn; Frédérique Nguyen
Journal:  Front Vet Sci       Date:  2019-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.